The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series. - Drenner K; Basu GD; Goodman LJ; Ozols AA; LoBello JR; Royce T; Gordon MS; Borazanci EH; Steinbach MA; Trent J; Sharma S (Oncotarget, 2021)